Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Phase II dose of anticancer agent CS-7017 selected

Nov. 5, 2008

PDGFRalpha antibody MEDI-575 characterized in vitro, in vivo

Nov. 5, 2008

OSI presents OXA-01 at EORTC-NCI-AACR Symposium

Nov. 5, 2008

Canopus reports results from specialized laboratory study of peptide cancer vaccine

Nov. 4, 2008

AEterna Zentaris initiates second stage of patient recruitment in phase II trial of AEZS-108

Nov. 4, 2008

FDA approves Treanda for relapsed indolent non-Hodgkin's lymphoma

Nov. 4, 2008

Interim results from a phase I solid tumor study with weekly EZN-2968

Nov. 4, 2008

Snapshots: Recent data on immunoconjugates from ImmunoGen

Nov. 4, 2008

Notch inhibition with MRK-003 active in preclinical pancreatic cancer experiments

Nov. 4, 2008

Spectrum files sNDA with FDA for Fusilev in colorectal cancer

Nov. 3, 2008

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...